Investor Alert

Company Close Updates Archives | Email alerts

Nov. 12, 2020, 5:02 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock rises Thursday, outperforms market

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP surged 13.11% to $1.38 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.65% to 11,709.59 and Dow Jones Industrial Average DJIA falling 1.08% to 29,080.17. Corbus Pharmaceuticals Holdings Inc. closed $8.40 below its 52-week high ($9.78), which the company achieved on August 31st.

The stock outperformed some of its competitors Thursday, as Fate Therapeutics Inc. FATE fell 2.62% to $51.98, Vanda Pharmaceuticals Inc. VNDA fell 1.03% to $12.95, and Viking Therapeutics Inc. VKTX fell 0.16% to $6.09. Trading volume (12.9 M) eclipsed its 50-day average volume of 6.0 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.